Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 StudiesHyun Cheol Chung, Patrick A. Ott, Steven Kao et al.|Journal of Thoracic Oncology|2019Cited by 437
The potential of herbal drugs to treat heart failure: The roles of Sirt1/AMPKTao Zhang, Xianli Meng, Lei Xu et al.|Journal of Pharmaceutical Analysis|2023Cited by 40